Intuitive Surgical (NASDAQ:ISRG) Stock Rating Upgraded by Wall Street Zen

Intuitive Surgical (NASDAQ:ISRG) was upgraded by equities research analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a note issued to investors on Saturday, Wall Street Zen reports.

Other analysts have also issued research reports about the stock. TD Cowen reaffirmed a “buy” rating and set a $485.00 target price on shares of Intuitive Surgical in a report on Monday, October 19th. BMO Capital Markets reaffirmed an “outperform” rating on shares of Intuitive Surgical in a report on Monday, July 20th. JPMorgan Chase & Co. lifted their target price on Intuitive Surgical from $450.00 to $475.00 and gave the company an “overweight” rating in a report on Wednesday, October 21st. Sanford C. Bernstein reaffirmed an “outperform” rating on shares of Intuitive Surgical in a report on Wednesday, August 12th. Finally, Oppenheimer reissued an “outperform” rating and set a $500.00 price target on shares of Intuitive Surgical in a research report on Wednesday, October 21st. One investment analyst has rated the stock with a Strong Buy rating, twenty-three have given a Buy rating, five have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $493.54.

Intuitive Surgical Stock Performance

Shares of NASDAQ ISRG opened at $432.01 on Friday. The firm’s 50 day moving average price is $401.54 and its 200 day moving average price is $434.05. The firm has a market cap of $149.75 billion, a P/E ratio of 52.24, a price-to-earnings-growth ratio of 2.98 and a beta of 1.45. Intuitive Surgical has a 1 year low of $328.57 and a 1 year high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share for the quarter, topping analysts’ consensus estimates of $2.65 by $0.35. The firm had revenue of $3.05 billion for the quarter, compared to analysts’ expectations of $2.91 billion. Intuitive Surgical had a return on equity of 18.17% and a net margin of 25.54%. Intuitive Surgical’s revenue was up 21.7% on a year-over-year basis. During the same quarter last year, the business posted $2.40 EPS. As a group, equities analysts predict that Intuitive Surgical will post 9.37 EPS for the current year.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, VP Fredrik Widman sold 4,047 shares of the company’s stock in a transaction that occurred on Friday, October 23rd. The shares were sold at an average price of $453.21, for a total transaction of $1,834,140.87. Following the transaction, the vice president owned 1,026 shares in the company, valued at approximately $464,993.46. This represents a 79.78% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Patricia L. Wadors sold 1,078 shares of Intuitive Surgical stock in a transaction dated Friday, October 23rd. The shares were sold at an average price of $443.80, for a total value of $478,416.40. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 38,778 shares of company stock valued at $16,814,967 in the last quarter. 0.60% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Intuitive Surgical

Institutional investors and hedge funds have recently modified their holdings of the stock. Beaumont Financial Advisors LLC increased its position in Intuitive Surgical by 3.8% during the third quarter. Beaumont Financial Advisors LLC now owns 627 shares of the medical equipment provider’s stock worth $255,000 after acquiring an additional 23 shares during the period. Hughes Financial Services LLC raised its stake in Intuitive Surgical by 40.7% in the 3rd quarter. Hughes Financial Services LLC now owns 83 shares of the medical equipment provider’s stock valued at $37,000 after acquiring an additional 24 shares during the period. W.G. Shaheen & Associates DBA Whitney & Co grew its holdings in shares of Intuitive Surgical by 1.0% during the 1st quarter. W.G. Shaheen & Associates DBA Whitney & Co now owns 2,542 shares of the medical equipment provider’s stock worth $1,172,000 after purchasing an additional 25 shares in the last quarter. Blue Fin Capital Inc. increased its position in Intuitive Surgical by 0.5% during the 1st quarter. Blue Fin Capital Inc. now owns 4,794 shares of the medical equipment provider’s stock valued at $2,210,000 after purchasing an additional 25 shares during the period. Finally, Red Spruce Capital LLC grew its stake in shares of Intuitive Surgical by 4.1% in the 2nd quarter. Red Spruce Capital LLC now owns 640 shares of the medical equipment provider’s stock worth $255,000 after acquiring an additional 25 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops and manufactures robotic-assisted systems and related technologies for minimally invasive surgery. Its products are designed to help surgeons perform procedures through small incisions while providing enhanced visualization, precision and control. The company’s primary platform is the da Vinci Surgical System, which is used across a range of specialties, including urology, gynecology, general surgery, cardiothoracic surgery and other procedures.

The company also offers the Ion endoluminal system, which is designed to support minimally invasive lung biopsy procedures.